• Please log in or register to access this feature.

Correspondence

You have full text access to this OnlineOpen article

To the Editor

  1. S. Nahum Goldberg M.D.1,
  2. Luigi Solbiati M.D.2

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510340327

Issue

Hepatology

Hepatology

Volume 34, Issue 3, page 609, September 2001

Additional Information

How to Cite

Goldberg, S. N. and Solbiati, L. (2001), To the Editor. Hepatology, 34: 609. doi: 10.1002/hep.510340327

Author Information

  1. 1

    Director, Minimally Invasive Therapies Laboratory, Director, CT Intervention and Tumor Ablation Therapy, Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA

  2. 2

    Director, Ultrasound and Intervention, Ospedale Generale Busto Arsizio, Italy

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (54K)

References

  • 1
    Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124–1129.MEDLINE
    Direct Link:
  • 2
    Kato T, Reddy KR. Radiofrequency Ablation for Hepatocellular Carcinoma: help or hazard? Hepatology 2001; 33:1336–1337.MEDLINE
    Direct Link:
  • 3
    Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN. Complications after cool-tip RF ablation of liver cancer: initial report of the Italian multicentre cooled-tip RF study group. Radiology 2000: 217(suppl):27A.
  • 4
    Di Stasi M, Ruscarini L, Livraghi T, Giorgio A, Salmi A, De Sio I, Brunello F, et al. Percutaneous ethanol injection therapy in the treatment of hepatocellular carcinoma—a multicenter survey of evaluation practices and complication rate. Scand J Gastroenterol 1997; 32:1168–1173.MEDLINE
  • 5
    Gervais DA, Goldberg SN, Arellano RS, Chung R, Mueller PR. Treatment of hepatocellular carcinoma in cirrhotic patients awaiting transplant: a new and evolving use of percutaneous radiofrequency ablation. Presented at 86th Scientific Assembly and Annual Meeting, RSNA Chicago IL, December 2000; 217(P)1664.
  • 6
    McGahan JP, Dodd G III. Radiofrequency ablation of the liver: current status. AJR 2001; 176:3–16.
Get PDF (54K)